HCA Healthcare Inc (NYSE: HCA) is 17.18% higher on its value in year-to-date trading and has touched a low of $215.96 and a high of $335.83 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HCA stock was last observed hovering at around $326.65 in the last trading session, with the day’s loss setting it -9.47%.
Currently trading at $317.18, the stock is 1.51% and -1.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing -2.90% at the moment leaves the stock 13.22% off its SMA200. HCA registered 14.05% gain for a year compared to 6-month gain of 39.38%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.75% loss in the last 1 month and extending the period to 3 months gives it a 2.26%, and is 2.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.59% over the week and 2.46% over the month.
HCA Healthcare Inc (HCA) has around 310000 employees, a market worth around $83.07B and $66.72B in sales. Current P/E ratio is 15.81 and Fwd P/E is 13.71. Profit margin for the company is 8.20%. Distance from 52-week low is 46.87% and -5.55% from its 52-week high. The company has generated returns on investments over the last 12 months (14.60%).
The EPS is expected to grow by 9.40% this year.
HCA Healthcare Inc (HCA) Top Institutional Holders
The shares outstanding are 265.54M, and float is at 189.60M with Short Float at 1.31%.
HCA Healthcare Inc (HCA) Insider Activity
The most recent transaction is an insider sale by Cuffe Michael S.,the company’sEVP and Chief Clinical Officer. SEC filings show that Cuffe Michael S. sold 6,311 shares of the company’s common stock on May 09 ’24 at a price of $316.88 per share for a total of $2.0 million. Following the sale, the insider now owns 29624.0 shares.
HCA Healthcare Inc disclosed in a document filed with the SEC on May 09 ’24 that Cohen Jeffrey E. (SVP-Government Relations) sold a total of 1,650 shares of the company’s common stock. The trade occurred on May 09 ’24 and was made at $313.00 per share for $0.52 million. Following the transaction, the insider now directly holds 5185.0 shares of the HCA stock.
Still, SEC filings show that on May 06 ’24, Cuffe Michael S. (EVP and Chief Clinical Officer) disposed off 1,600 shares at an average price of $309.00 for $0.49 million. The insider now directly holds 34,124 shares of HCA Healthcare Inc (HCA).
